Authors
Bazilevich A.V., Sidorov R.V., Haisheva L.A.
Rostov State Medical University, Rostov-on-Don
Abstract
Global mortality statistics give coronary heart disease a leading role. Surgical treatment remains the gold standard for improving prognosis and quality of life in these patients. Comorbid pathology, such as type 2 diabetes mellitus and chronic kidney disease, significantly increases the severity of ischemic heart disease, as well as the incidence of perioperative complications and the duration of the rehabilitation period. There are several methods of coronary artery atherosclerosis surgical treatment, such as: percutaneous coronary intervention, coronary artery bypass grafting, as well as a relatively new method of hybrid myocardial revascularization. The decision on the choice of surgical treatment method is made by the Heart Team, which should also include a specialist in the relevant comorbid pathology. Percutaneous coronary interventions are statistically more likely to result in the need for repeat myocardial revascularization than coronary artery bypass grafting. However, open major intervention is accompanied with a great number of postoperative complications and prolonged patient rehabilitation period. Hybrid myocardial revascularization is an alternative method that reduces the risks of adverse complications of multivessel coronary bypass and balloon angioplasty with coronary artery stenting and combines the advantages of both procedures. The choice of the optimal strategy of surgical treatment in patients with comorbid pathology requires special attention.
Keywords: ischemic heart disease, diabetes mellitus, chronic kidney disease, coronary artery atherosclerosis surgical treatment, percutaneous coronary intervention, coronary artery bypass grafting, hybrid myocardial revascularization.
References
1. Buddeke J, Bots ML, van Dis I, et al. Comorbidity in patients with cardiovascular disease in primary care: a cohort study with routine healthcare data. Br J Gen Pract. 2019; 69(683): e398-e406. doi: 10.3399/bjgp19X702725.
2. Kendir C, van den Akker M, Vos R, Metsemakers J. Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands. Eur J Gen Pract. 2018; 24(1): 45-50. doi: 10.1080/ 13814788.2017.1398318.
3. Barbarash OL., Semjonov VYu, Samorodskaya IV, et al. Comorbidity in coronary heart disease patients undergoing bypass grafting: an experience of two surgery centers. Russ J Cardiol. 2017, 3(143): 6-13. (In Russ.) doi: 10.15829/ 1560-4071-2017-3-6-13.
4. Rossijskoe kardiologicheskoe obshchestvo. Stabil’naya ishemicheskaya bolezn’ serdca. Klinicheskie rekomendacii 2020. Rossijskij kardiologicheskij zhurnal. 2020; 25(11): 4076. (In Russ.) doi: 10.15829/1560-4071-2020-4076.
5. Rekomendacii ESC/EACTS po revaskulyarizacii miokarda 2018. Rossijskij kardiologicheskij zhurnal. 2019; №8: 151-226. (In Russ.) doi: 10.15829/1560-4071-2019-8-151-226.
6. Wang R, Serruys PW, Gao C, et al. Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease. Eur Heart J. 2021; 43(1): 56-67. doi: 10.1093/ eurheartj/ehab441.
7. Shevchenko YuL, Susov RP. Infectious and inflammatory complications after operations in cardiothoracic surgery. Bulletin of Pirogov National Medical & Surgical Center. 2022; 17(1): 84-89. (In Russ.) doi: 10.25881/20728255_2022_17_1_84.
8. Han P, Yu H, Xie F, et al. Effects of early rehabilitation on functional outcomes in patients after coronary artery bypass graft surgery: a randomized controlled trial. J Int Med Res. 2022; 50(3): 3000605221087031. doi: 10.1177/03000605221087031.
9. Antsygina LN, Kordatov PN. Principles of rehabilitation of patients with ischemic heart disease after surgical revascularization of myocardium. Physical and rehabilitation medicine, medical rehabilitation. 2020; 2(2): 190-199. (In Russ.) doi: 10.36425/rehab34111.
10. Zenkov AA. Life quality analysis on the application of different methods of surgical myocardial revascularization: prospective randomized trial micsrevs. 2018: 17(1): 68-80. (In Russ.) doi: 10.22263/2312-4156.2018.1.68.
11. Nolan S, Filion KB, Atallah R, Moss E, Reynier P, Eisenberg MJ. Hybrid Coronary Revascularization vs Complete Coronary Artery Bypass Grafting for Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis. J Invasive Cardiol. 2018; 30(12): E131-E149.
12. Xenogiannis I, Zenati M, Bhatt DL, et al. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies. Circulation. 2021; 144(9): 728-745. doi: 10.1161/CIRCULATIONAHA.120.052163.
13. Ren J, Royse C, Srivastav N, Lu O, Royse A. Long-Term Survival of Multiple Versus Single Arterial Coronary Bypass Grafting in Elderly Patients. J Clin Med. 2023; 12(7): 2594. doi: 10.3390/jcm12072594.
14. Yu L, Zhu K, Du N, et al. Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: a meta-analysis. J Cardiothorac Surg. 2022; 17(1): 147. doi: 10.1186/s13019-022-01903-w.
15. Nenna A, Nappi F, Spadaccio C, et al. Hybrid coronary revascularization in multivessel coronary artery disease: a systematic review. Future Cardiol. 2022; 18(3): 219-234. doi: 10.2217/fca-2020-0244.
16. Van den Eynde J, Sá MP, De Groote S, et al. Hybrid coronary revascularization versus percutaneous coronary intervention: A systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2021; 37: 100916. doi: 10.1016/j.ijcha.2021.100916.
17. Moreno PR, Stone GW, Gonzalez-Lengua CA, Puskas JD. The Hybrid Coronary Approach for Optimal Revascularization: JACC Review Topic of the Week. J Am Coll Cardiol. 2020; 76(3): 321-333. doi: 10.1016/j.jacc. 2020.04.078.
18. Purmessur R, Wijesena T, Ali J. Minimal-Access Coronary Revascularization: Past, Present, and Future. J Cardiovasc Dev Dis. 2023; 10(8): 326. doi: 10.3390/jcdd10080326.
19. Sanetra K, Buszman PP, Jankowska-Sanetra J, et al. One-stage hybrid coronary revascularization for the treatment of multivessel coronary artery disease- Periprocedural and long-term results from the “HYBRID-COR” feasibility study. Front Cardiovasc Med. 2022; 9: 1016255. doi: 10.3389/ fcvm.2022.1016255.
20. Fuchs-Buder T, Settembre N, Schmartz D. Hybridoperationssaal. Anaesthesist. 2018; 67(7): 480-487. doi: 10.1007/s00101-018-0464-z.
21. Bhat S, Yatsynovich Y, Sharma UC. Coronary revascularization in patients with stable coronary disease and diabetes mellitus. Diab Vasc Dis Res. 2021; 18(2): 14791641211002469. doi: 10.1177/14791641211002469.
22. Shсhukina EV, Prikolota OA, Bagrij VA, et al. Treatment of Patients Chronic Coronary Heart Disease and Type 2 Diabetes Mellitus. The Russian Archives of Internal Medicine. 2023; 13(2): 97-109. (In Russ.) doi: 10.20514/ 2226-6704-2023-13-2-97-109.
23. Mancini GBJ, Boden WE, Brooks MM, et al. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials. Atherosclerosis. 2018; 277: 186-194. doi: 10.1016/j.atherosclerosis.2018.04.005.
24. Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. Circulation. 2022; 145(9): e722-e759. doi: 10.1161/CIR.0000000000001040.
25. Li D, Guo Y, Gao Y, et al. One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting in Patients With Multivessel Coronary Artery Disease. Front Cardiovasc Med. 2021; 8: 755797. doi: 10.3389/fcvm.2021.755797.
26. Rzhevskaya ON, Moiseyeva AY, Esaulenko AN, et al. Chronic Kidney Disease and Myocardial Infarction. Russian Sklifosovsky Journal “Emergency Medical Care”. 2022; 11(1): 104-118. (In Russ.) doi: 10.23934/ 2223-9022-2022-11-1-104-118.
27. Bangalore S, Maron DJ, O’Brien SM, et al. Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med. 2020; 382 (17): 1608-1618. doi: 10.1056/NEJMoa1915925.
28. Li D, Gao J, Guo Y, et al. Risk factor analysis of acute kidney injury after one-stop hybrid coronary revascularization. Ann Palliat Med. 2021; 10(7): 7398-7405. doi: 10.21037/apm-21-959.
29. Wintgen L, Dakkak AR, Shakaki MA, et al. Acute kidney injury following coronary artery bypass grafting and control angiography: a comprehensive analysis of 221 patients. Heart Vessels. 2021; 36(1): 1-6. doi: 10.1007/ s00380-020-01655-4.
30. Sarnak MJ, Amann K, Bangalore S, et al. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019; 74(14): 1823-1838. doi: 10.1016/j.jacc.2019.08.1017.
